| scholarly article | Q13442814 |
| P356 | DOI | 10.1592/PHCO.30.1.43 |
| P698 | PubMed publication ID | 20030472 |
| P50 | author | Eshetu G. Atenafu | Q41348687 |
| L Lee Dupuis | Q73903348 | ||
| P2093 | author name string | Ahmed Naqvi | |
| Cathryn Sibbald | |||
| Sabrina Boodhan | |||
| Cecile Wong | |||
| Miriam Inparajah | |||
| P2860 | cites work | 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer | Q34114674 |
| A suggested approach to once‐daily aminoglycoside dosing | Q34347273 | ||
| Once daily ceftriaxone and gentamicin for the treatment of febrile neutropenia. | Q35262273 | ||
| Pharmacodynamics and dosing of aminoglycosides | Q35623060 | ||
| Population pharmacokinetics of gentamicin in patients with cancer | Q35802610 | ||
| Extended-interval aminoglycoside administration for children: a meta-analysis | Q35825369 | ||
| An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients | Q36247321 | ||
| Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study | Q36536423 | ||
| Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia | Q37298859 | ||
| Suboptimal aminoglycoside dosing in critically ill patients | Q37341556 | ||
| Randomized controlled trial of once- versus thrice-daily tobramycin in febrile neutropenic children undergoing stem cell transplantation | Q40543758 | ||
| Pharmacokinetic analysis of gentamicin thrice and single daily dosage in pediatric cancer patients | Q40643970 | ||
| Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia i | Q40653024 | ||
| Once daily antibiotic regimen in paediatric oncology | Q42011952 | ||
| Experience with a once-daily dosing program of aminoglycosides in critically ill patients | Q44067363 | ||
| Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 | ||
| Tobramycin pharmacokinetics in children with febrile neutropenia undergoing stem cell transplantation: once-daily versus thrice-daily administration | Q44910304 | ||
| Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial | Q45262881 | ||
| Use of pharmacokinetics and pharmacodynamics to optimize antimicrobial treatment of Pseudomonas aeruginosa infections | Q45265803 | ||
| Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patients. | Q51756288 | ||
| Prediction of the distribution volumes of cefazolin and tobramycin in obese children based on physiological pharmacokinetic concepts. | Q52425413 | ||
| Effect of Obesity on Gentamicin Pharmacokinetics | Q59157843 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gentamicin | Q422482 |
| P304 | page(s) | 43-51 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Pharmacotherapy | Q7180800 |
| P1476 | title | Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy | |
| P478 | volume | 30 |
| Q38680501 | A Population Pharmacokinetic Model of Gentamicin in Pediatric Oncology Patients To Facilitate Personalized Dosing |
| Q37813680 | Advances in paediatric pharmacokinetics |
| Q37376795 | High-Dose, Extended-Interval Gentamicin and Tobramycin for Pediatric Inpatients: A Survey of Canadian Hospital Pharmacists |
| Q37956403 | Pharmacological considerations for the proper clinical use of aminoglycosides |
Search more.